AI news ·
UK medicines regulator plans AI safety tools by 2030
The UK’s medicines regulator plans to use AI tools for safety checks and trial reviews by 2030, and will set clearer rules for AI medical products.

The UK’s Medicines and Healthcare products Regulatory Agency is developing artificial intelligence tools intended to support safety surveillance and the checking of clinical trial protocols. The agency is also working on clearer rules for AI-based medical products. The plans set a target for these operational tools to be in place by 2030.
The move signals a shift within regulatory bodies from policy discussion toward building and deploying practical systems. The planned tools are designed to assist in monitoring the safety of medicines and devices, and in reviewing trial documentation, though the specific technical methods have not been detailed.
For professionals in government, healthcare, insurance, legal and research roles, the development points to a future regulatory environment where AI-supported processes may become part of standard oversight. The commitment to clearer rules for AI medical products also indicates that manufacturers and developers will face more defined expectations as these technologies reach the market.